Preliminary evaluation of a multicenter, randomized comparative study of TAXOL (paclitaxel) dose and infusion length in platinum-treated ovarian cancer
- 1 October 1993
- journal article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 19, 79-86
- https://doi.org/10.1016/0305-7372(93)90050-2
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Long-term survival in ovarian cancerEuropean Journal of Cancer and Clinical Oncology, 1991
- Sequences of taxol and cisplatin: a phase I and pharmacologic study.Journal of Clinical Oncology, 1991
- Taxol: A Novel Investigational Antimicrotubule AgentJNCI Journal of the National Cancer Institute, 1990
- Taxol: A Unique Antineoplastic Agent with Significant Activity in Advanced Ovarian Epithelial NeoplasmsAnnals of Internal Medicine, 1989
- Predictability of the survival of patients with advanced ovarian cancer.Journal of Clinical Oncology, 1989
- Reporting results of cancer treatmentCancer, 1981